Insider · CIK 0001236371

PERRY GREGORY D

Reports to the SEC for 10 companies · WALTHAM, MA

sec.gov

Transactions

Companies

Filings

CIK

0001236371

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-12-12	MRUSMerus N.V. · Share Option (right to buy)D Disposition to Issuer	Chief Financial Officer & PFO	DDisposition to Issuer	−14.4K sh	—	—	0
2025-12-12	MRUSMerus N.V. · Share Option (right to buy)D Disposition to Issuer	Chief Financial Officer & PFO	DDisposition to Issuer	−5,650 sh	—	—	0
2025-12-12	MRUSMerus N.V. · Share Option (right to buy)D Disposition to Issuer	Chief Financial Officer & PFO	DDisposition to Issuer	−373K sh	—	—	0
2025-12-12	MRUSMerus N.V. · Share Option (right to buy)D Disposition to Issuer	Chief Financial Officer & PFO	DDisposition to Issuer	−100K sh	—	—	0
2025-12-12	MRUSMerus N.V. · Share Option (right to buy)D Disposition to Issuer	Chief Financial Officer & PFO	DDisposition to Issuer	−8,631 sh	—	—	0
2025-12-12	MRUSMerus N.V. · Share Option (right to buy)D Disposition to Issuer	Chief Financial Officer & PFO	DDisposition to Issuer	−8,500 sh	—	—	0
2025-12-12	MRUSMerus N.V. · Share Option (right to buy)D Disposition to Issuer	Chief Financial Officer & PFO	DDisposition to Issuer	−17K sh	—	—	0
2025-12-12	MRUSMerus N.V. · Share Option (right to buy)D Disposition to Issuer	Chief Financial Officer & PFO	DDisposition to Issuer	−6,120 sh	—	—	0
2025-12-12	MRUSMerus N.V. · Share Option (right to buy)D Disposition to Issuer	Chief Financial Officer & PFO	DDisposition to Issuer	−107K sh	—	—	0
2025-12-12	MRUSMerus N.V. · Share Option (right to buy)D Disposition to Issuer	Chief Financial Officer & PFO	DDisposition to Issuer	−4,983 sh	—	—	0
2025-12-12	MRUSMerus N.V. · Share Option (right to buy)D Disposition to Issuer	Chief Financial Officer & PFO	DDisposition to Issuer	−16.6K sh	—	—	0
2025-06-15	KALAKALA BIO, Inc. · Stock Option (right to buy)A Award	Director	AAward	+5,450 sh	—	—	5,450
2025-06-15	KALAKALA BIO, Inc.A Award	Director	AAward	+2,450 sh	—	—	13,344
2025-01-29	MRUSMerus N.V. · Share Option (right to buy)A Award	Chief Financial Officer & PFO	AAward	+100K sh	—	—	100,000
2024-06-11	KALAKALA BIO, Inc. · Stock Option (right to buy)A Award	Director	AAward	+3,150 sh	—	—	3,150
2024-06-11	KALAKALA BIO, Inc.A Award	Director	AAward	+1,400 sh	—	—	10,894
2024-05-07	MRUSMerus N.V. · Share Option (right to buy)A Award	Chief Financial Officer & PFO	AAward	+107K sh	—	—	107,300
2023-06-22	KALAKALA BIO, Inc.A Award	Director	AAward	+1,100 sh	—	—	9,494
2023-06-22	KALAKALA BIO, Inc. · Stock Option (right to buy)A Award	Director	AAward	+7,808 sh	—	—	7,808
2023-06-22	KALAKALA BIO, Inc.A Award	Director	AAward	+5,856 sh	—	—	8,394
2023-06-22	KALAKALA BIO, Inc. · Stock Option (right to buy)A Award	Director	AAward	+2,500 sh	—	—	2,500
2023-06-14	MRUSMerus N.V. · Share option (right to buyA Award	Chief Financial Officer & PFO	AAward	+373K sh	—	—	372,924
2023-06-08	MRUSMerus N.V. · Share option (right to buy)A Award	Chief Financial Officer & PFO	AAward	+14.4K sh	—	—	14,414
2023-05-31	KALAKALA BIO, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−518 sh	—	—	0
2023-05-31	KALAKALA BIO, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−420 sh	—	—	0
2023-05-31	KALAKALA BIO, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−800 sh	—	—	0
2023-05-31	KALAKALA BIO, Inc.A Award	Director	AAward	+1,738 sh	—	—	2,538
2022-06-16	KALAKALA BIO, Inc. · Stock Option (right to buy)A Award	Director	AAward	+40K sh	—	—	40,000
2022-05-31	MRUSMerus N.V. · Share option (right to buy)A Award	Chief Financial Officer & PFO	AAward	+16.6K sh	—	—	16,604
2022-02-25	FNCHFinch Therapeutics Group, Inc. · Employee Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+80K sh	—	—	80,000
2021-06-17	KALAKALA BIO, Inc.A Award	Director	AAward	+20K sh	—	—	40,000
2021-05-28	MRUSMerus N.V. · Share option (right to buy)A Award	Chief Financial Officer & PFO	AAward	+6,120 sh	—	—	6,120
2021-03-18	FNCHFinch Therapeutics Group, Inc. · Employee Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+55.4K sh	—	—	55,386
2020-06-30	MRUSMerus N.V. · Share Option (right to buy)A Award	Chief Financial Officer & PFO	AAward	+8,631 sh	—	—	8,631
2020-06-25	KALAKALA BIO, Inc.A Award	Director	AAward	+20K sh	—	—	20,000
2019-06-05	KALAKALA BIO, Inc. · Stock Option (right to buy)A Award	Director	AAward	+21K sh	—	—	21,000
2018-02-28	KALAKALA BIO, Inc. · Stock Option (right to buy)A Award	Director	AAward	+25.9K sh	—	—	25,920
2017-05-09	NOVELION THERAPEUTICS INC.F Tax Payment	See Remarks	FTax Payment	−710 sh	$9.42	−$6,688.2	1,683
2017-05-09	NOVELION THERAPEUTICS INC.Restricted Stock UnitsM Exercise/Conversion	See Remarks	MExercise/Conversion	−2,393 sh	—	—	4,786
2017-05-09	NOVELION THERAPEUTICS INC.M Exercise/Conversion	See Remarks	MExercise/Conversion	+2,393 sh	—	—	2,393
2016-12-22	NOVELION THERAPEUTICS INC.Stock Option (right to buy)A Award	See Remarks	AAward	+166K sh	—	—	166,020
2016-11-29	Aegerion Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	See Remarks	DDisposition to Issuer	−69K sh	—	—	0
2016-11-29	Aegerion Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	See Remarks	DDisposition to Issuer	−200K sh	—	—	0
2016-11-29	Aegerion Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	See Remarks	DDisposition to Issuer	−40K sh	—	—	0
2016-11-29	Aegerion Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	See Remarks	DDisposition to Issuer	−200K sh	—	—	0
2016-11-29	NOVELION THERAPEUTICS INC.Restricted Stock UnitsA Award	See Remarks	AAward	+35.9K sh	—	—	35,896
2016-11-29	Aegerion Pharmaceuticals, Inc.Restricted Stock UnitsD Disposition to Issuer	See Remarks	DDisposition to Issuer	−35K sh	—	—	0
2016-05-09	Aegerion Pharmaceuticals, Inc.Restricted Stock UnitsA Award	See Remarks	AAward	+35K sh	—	—	35,000
2016-05-09	Aegerion Pharmaceuticals, Inc.Stock Option (right to buy)A Award	See Remarks	AAward	+69K sh	—	—	69,000
2016-02-12	Aegerion Pharmaceuticals, Inc.Stock Option (right to buy)A Award	See Remarks	AAward	+200K sh	—	—	200,000

Recent filings

Accepted (ET)
Dec 124
PERRY GREGORY D0001193125-25-317968
SEC(opens sec.gov)
Jun 174
PERRY GREGORY D0001415889-25-017613
SEC(opens sec.gov)
Jan 314
PERRY GREGORY D0000950170-25-011795
SEC(opens sec.gov)
Jun 124
PERRY GREGORY D0001415889-24-016572
SEC(opens sec.gov)
May 94
PERRY GREGORY D0000950170-24-057092
SEC(opens sec.gov)
Jun 234
PERRY GREGORY D0001415889-23-010290
SEC(opens sec.gov)

Companies

Address

C/O IMMUNOGEN, INC. 830 WINTER STREET

WALTHAM, MA, 02451